These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 15659402

  • 1. Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site.
    Leo E, Gould KA, Pan XS, Capranico G, Sanderson MR, Palumbo M, Fisher LM.
    J Biol Chem; 2005 Apr 08; 280(14):14252-63. PubMed ID: 15659402
    [Abstract] [Full Text] [Related]

  • 2. Functional determinants of gate-DNA selection and cleavage by bacterial type II topoisomerases.
    Arnoldi E, Pan XS, Fisher LM.
    Nucleic Acids Res; 2013 Nov 08; 41(20):9411-23. PubMed ID: 23939623
    [Abstract] [Full Text] [Related]

  • 3. Cleavable-complex formation by wild-type and quinolone-resistant Streptococcus pneumoniae type II topoisomerases mediated by gemifloxacin and other fluoroquinolones.
    Yague G, Morris JE, Pan XS, Gould KA, Fisher LM.
    Antimicrob Agents Chemother; 2002 Feb 08; 46(2):413-9. PubMed ID: 11796351
    [Abstract] [Full Text] [Related]

  • 4. Hot-spot consensus of fluoroquinolone-mediated DNA cleavage by Gram-negative and Gram-positive type II DNA topoisomerases.
    Richter SN, Giaretta G, Comuzzi V, Leo E, Mitchenall LA, Fisher LM, Maxwell A, Palumbo M.
    Nucleic Acids Res; 2007 Feb 08; 35(18):6075-85. PubMed ID: 17766248
    [Abstract] [Full Text] [Related]

  • 5. Methods to assay inhibitors of DNA gyrase and topoisomerase IV activities.
    Fisher LM, Pan XS.
    Methods Mol Med; 2008 Feb 08; 142():11-23. PubMed ID: 18437302
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.
    Hardy CD, Cozzarelli NR.
    Antimicrob Agents Chemother; 2003 Mar 08; 47(3):941-7. PubMed ID: 12604525
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claims.
    Smith HJ, Nichol KA, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2002 Jun 08; 49(6):893-5. PubMed ID: 12039880
    [No Abstract] [Full Text] [Related]

  • 16. Highly sensitive mapping of in vitro type II topoisomerase DNA cleavage sites with SHAN-seq.
    Morgan IL, McKie SJ, Kim R, Seol Y, Xu J, Harami GM, Maxwell A, Neuman KC.
    Nucleic Acids Res; 2024 Sep 09; 52(16):9777-9787. PubMed ID: 39106172
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS, Fisher LM.
    J Bacteriol; 1996 Jul 09; 178(14):4060-9. PubMed ID: 8763932
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The mechanism of negative DNA supercoiling: a cascade of DNA-induced conformational changes prepares gyrase for strand passage.
    Gubaev A, Klostermeier D.
    DNA Repair (Amst); 2014 Apr 09; 16():23-34. PubMed ID: 24674625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.